Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress

NCT03642028 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT03642028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03642028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Recruiting
Start date
August 30, 2019
Completion date
December 31, 2025
Enrollment
190 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

sleep initiation and maintenance disorders, stress disorders, posttraumatic